Mediwelcome Healthcare Management & Technology Inc. Announces Significant Reduction in Loss for FY2025

Key Highlights

• Profit Warning – Reduction in Loss: Mediwelcome Healthcare Management & Technology Inc. has issued a profit warning, anticipating a substantial narrowing of losses for the financial year ended 31 December 2025.
• Improvement Over Previous Year: The company expects its results to show a significant improvement compared to the year ended 31 December 2024.
• Focus on Core Business and Higher-Margin Projects: The reduction in loss is mainly attributed to the continuous improvement in the performance of its core principal business and a strategic focus on higher-margin projects, which have boosted overall gross profit.
• Uncertainty Around Profit: While losses have narrowed substantially, management cautions that it is still uncertain whether the Group will record an actual profit for FY2025.
• Annual Results Pending: The Group is finalising its annual results, which are expected to be announced in late March 2026.
• Unaudited Figures: All information provided is based on unaudited consolidated management accounts and may be subject to further adjustments.
• Board Composition: The Board consists of four executive directors, one non-executive director, and three independent non-executive directors, highlighting a diversified leadership structure.

Details for Investors and Shareholders

Potential Price Sensitivity

The news of a significant reduction in loss for FY2025 could be highly price sensitive. Investors and shareholders should note:

• The company’s improved financial performance may positively impact investor sentiment and share prices, especially if the narrowing of losses is greater than market expectations.
• The continued focus on core and higher-margin business segments suggests a strategic shift towards increased profitability, which could further strengthen the company’s market position.
• The announcement cautions that actual profits have not yet been confirmed, and final numbers will be disclosed only after further assessment and audit, which could introduce volatility or uncertainty until the official results are released.
• The company’s warning that the information is based on unaudited accounts means that figures may change, and this should be carefully considered by investors when making decisions.

Important Considerations for Shareholders

• Shareholders and potential investors are strongly advised to exercise caution when dealing in the company’s securities until the official annual results are published.
• The official annual results announcement is expected in late March 2026, which will provide clearer insight into the company’s financial position and may impact trading activity.
• The Board’s statement highlights the importance of waiting for the audited results to make informed investment decisions.

Leadership Update

The announcement is signed by Shi Wei, Chairman and Executive Director, and lists the current board members, reflecting a mix of executive, non-executive, and independent directors, which may reassure investors about governance and oversight.

Conclusion

Mediwelcome Healthcare Management & Technology Inc.’s announcement of a substantial reduction in losses for FY2025, driven by improved core business performance and a pivot to higher-margin projects, is a positive signal for shareholders and investors. However, the company advises caution until audited results are available in late March 2026, as the current information is based on preliminary unaudited accounts and may be subject to change. This update is potentially price-sensitive and could influence the company’s share price depending on market expectations and the final financial outcome.

Disclaimer: This article is based on preliminary unaudited information provided by Mediwelcome Healthcare Management & Technology Inc. Investors and shareholders should exercise caution and await the official audited results before making investment decisions. The information herein does not constitute financial advice or a recommendation to buy or sell securities.

View MEDIWELCOME Historical chart here